The U.S. Health Resources Services Administration (HRSA) has ordered a Michigan-based manufacturer of over-the-counter (OTC) drugs that it audited to repay 340B covered entities because it did not offer its products at the statutory ceiling price.
HRSA posted the findings of its audit of Chain Drug Marketing Association (CDMA) in April. CDMA is a Novi, Mich.-based cooperative association of pharmacy and retail businesses. It manufactures and distributes such OTC products as painkillers, allergy medications, cold medications, and antacids products under the Quality Choice brand, a private label common in supermarkets and chain and local pharmacies. Walmart offers a wide array of Quality Choice products.
The U.S. Health Resources Services Administration (HRSA) has ordered a Michigan-based manufacturer of over-the-counter (OTC) drugs that it audited to repay 340B covered entities because it did not offer its products at the statutory ceiling price.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
